Data Bridge Market Research analyses that the cold sore treatment market was valued at USD 825.24 million in 2022 and is expected to reach USD 1,376.06 million by 2030, registering a CAGR of 6.60% during the forecast period of 2023 to 2030. ‘”Antiviral agents” dominates therapeutics type segment in the market as most of the cold are caused by common viral cold fever.
A cold sore is a fluid-filled blister that occurs on the lips or around the mouth. Fever blisters, oral herpes, and herpes labialis are all terms used to describe cold sores. Herpes simplex is the virus that causes them. Herpes simplex virus 1 is the most prevalent strain of the virus that causes cold sores. Antiviral ointments, including acyclovir and penciclovir, are applied on sores as part of the treatment. These may work for some people, but they are frequently ineffective. Antiviral oral drugs such as famciclovir, acyclovir and valacyclovir can help reduce the duration and severity of sores.
Sample Report of Cold Sore Treatment Market Report : https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cold-sore-treatment-market
Cold Sore Treatment Market Scope and Market Size
The cold sore treatment market is segmented on the basis of strain type, therapeutics type, drug type, dosage form, route of administration, end-users, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Strain Type
- Herpes Simplex Type-1 Virus
- Herpes Simplex Type-2 Virus
Therapeutics Type
- Antiviral Agents
- Acyclovir
- Valacyclovir
- Famciclovir
- Penciclovir
- Analgesic Agents
- Lysine
- Rhubarb and sage
- Propolis
- Others
Drug Type
- Branded
- Generics
- Dosage Form
- Tablet
- Capsule
- Ointment
- Others
Route of Administration
- Oral
- Topical
- Others
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Key Players: Cold Sore Treatment Market
- Pfizer Inc. (U.S.)
- GlaxoSmithKline plc (U.K.)
- Novartis AG (Switzerland)
- Mylan N.V. (U.S.),
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sanofi (France)
- AstraZeneca (U.K.)
- Johnson & Johnson Private Limited (U.S.)
- Merck & Co., Inc. (U.S.)
MAJOR TOC OF THE REPORT
Chapter One: Cold Sore Treatment Market Overview
Chapter Two: Cold Sore Treatment Market Manufacturers Profiles
Chapter Three: Cold Sore Treatment Market competition, by Players
Chapter Four: Cold Sore Treatment Market Size by Regions
Get Detail TOC@ https://www.databridgemarketresearch.com/toc/?dbmr=global-cold-sore-treatment-market
Key Report Highlights
Comprehensive pricing analysis based on different product types and regional segments
Market size data in terms of revenue and sales volume
Deep insights about regulatory and investment scenarios of the global Wearable Devices in Sports Market
Analysis of market effect factors and their impact on the forecast and outlook of the Cold Sore Treatment Market
The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the global Wearable Devices in Sports Market
Key Questions Answered in Report:
What will the Cold Sore Treatment Market Demand and what will be Growth?
What are the latest opportunities for Cold Sore Treatment Market in the future?
What are the strengths of the key players?
Which region accounted for the largest Cold Sore Treatment Market share?
Access Full Report @: https://www.databridgemarketresearch.com/reports/global-cold-sore-treatment-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse Related Reports@
French (Français)
Spanish (Español)
Arabic
Portuguese (Português)
Deutsch
Turkish (Türk)
Dutch (Nederlands)
Italiano
Romaian (Română)
Português (Brasil)
Greek (Ελληνικά)
Russian (русский)